HTG Molecular Diagnostics, Inc. (HTGM) Financial Statements (2024 and earlier)

Company Profile

Business Address 3430 E. GLOBAL LOOP
TUCSON, AZ 85706
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,2116,53014,09921,56321,94325,417
Cash and cash equivalents12,2113,2125,75714,6149,60010,230
Short-term investments 3,3188,3426,94912,34315,188
Receivables1,4229601,2597492,0921,905
Inventory, net of allowances, customer advances and progress billings9091,6901,9562,0221,9882,341
Inventory9091,6901,9562,0221,9882,341
Other undisclosed current assets1,1101,5912,0111,0821,1632,082
Total current assets:15,65110,77219,32525,41727,18731,745
Noncurrent Assets
Inventory, Noncurrent  1,008    
Operating lease, right-of-use asset1,0071,0401,1431,2451,3451,444
Property, plant and equipment5986557819421,1191,219
Other noncurrent assets52113695786180999
Total noncurrent assets:2,1262,8382,8813,0473,2742,762
TOTAL ASSETS:17,77813,61022,20528,46430,46134,507
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,3672,9592,9692,3423,6722,755
Employee-related liabilities870515  
Accounts payable1,1577101,1191,3171,6491,146
Accrued liabilities2,2101,3781,3341,0252,0231,609
Deferred revenue     125213
Debt3,8123,6956,6155,0165,1684,185
Asset retirement obligation446473524548548531
Other liabilities1701291381811718
Other undisclosed current liabilities475(435)(86)407414381
Total current liabilities:8,2716,82110,1598,4949,9448,082
Noncurrent Liabilities
Long-term debt and lease obligation  1,9422,7794,9156,1597,400
Long-term debt, excluding current maturities  1,3022,0244,0465,1796,309
Finance lease, liability  1923273135
Liabilities, other than long-term debt4,1153,6594,4534,6553,9894,173
Asset retirement obligations3,5193,5953,6473,7253,9014,073
Other liabilities506380693088100
Operating lease, liability5466217328419491,056
Other undisclosed noncurrent liabilities(15)(19)(755)(870)(49)(73)
Total noncurrent liabilities:4,1005,5816,4778,70010,10011,500
Other undisclosed liabilities15  11738
Total liabilities:12,38612,40216,63617,19620,06119,620
Equity
Equity, attributable to parent5,3921,2085,57011,26810,40014,887
Preferred stock     00
Common stock21111988
Additional paid in capital235,314226,443226,293226,091218,723218,019
Accumulated other comprehensive income (loss)3(11)(16)(0)23
Accumulated deficit(229,928)(225,235)(220,719)(214,831)(208,333)(203,142)
Total equity:5,3921,2085,57011,26810,40014,887
TOTAL LIABILITIES AND EQUITY:17,77813,61022,20528,46430,46134,507

Income Statement (P&L) ($ in thousands)

3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
Revenues2,4391,2511,4921,1842,8772,520
Cost of revenue
(Cost of Goods and Services Sold)
(2,032)(671)(1,014)(855)(1,355)(984)
Gross profit:4085804773291,5221,537
Operating expenses(4,958)(4,928)(6,154)(6,583)(6,452)(5,767)
Operating loss:(4,551)(4,348)(5,677)(6,254)(4,930)(4,230)
Nonoperating expense(138)(167)(206)(243)(260)(258)
Interest and debt expense(168)(200)(239)(249)(267)(267)
Loss from continuing operations before equity method investments, income taxes:(4,857)(4,715)(6,122)(6,746)(5,457)(4,755)
Other undisclosed income from continuing operations before income taxes168200239249267267
Loss from continuing operations before income taxes:(4,689)(4,515)(5,883)(6,497)(5,189)(4,489)
Income tax expense(4)(2)(5)(0)(2)(2)
Loss from continuing operations:(4,693)(4,516)(5,888)(6,498)(5,191)(4,491)
Loss before gain (loss) on sale of properties:(4,516)(5,888)(6,498)(5,191)(4,491)
Net loss available to common stockholders, diluted:(4,693)(4,516)(5,888)(6,498)(5,191)(4,491)

Comprehensive Income ($ in thousands)

3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
Net loss:(4,693)(4,516)(5,888)(6,498)(5,191)(4,491)
Other comprehensive income (loss) 5(15)(2)(1)(1)
Other undisclosed comprehensive income 12     
Comprehensive loss:(4,680)(4,511)(5,904)(6,500)(5,192)(4,492)
Other undisclosed comprehensive income, net of tax, attributable to parent 1     
Comprehensive loss, net of tax, attributable to parent:(4,679)(4,511)(5,904)(6,500)(5,192)(4,492)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: